Nolan Mangini Siobhan 4
4 · NGM BIOPHARMACEUTICALS INC · Filed Mar 18, 2021
Insider Transaction Report
Form 4
Nolan Mangini Siobhan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-03-17+50,000→ 50,000 totalExercise: $31.93Exp: 2031-03-16→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option vest over a four-year period commencing January 1, 2021, with 1/48th of the shares vesting on a monthly basis.